Literature DB >> 6252144

beta-Lactamase stability of cefotaxime.

M H Richmond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6252144     DOI： 10.1093/jac/6.suppl_a.13

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

1.  Epidemiology of intestinal colonization by members of the family Enterobacteriaceae resistant to cefotaxime in a hematology-oncology unit.

Authors:  M H Prevot; A Andremont; H Sancho-Garnier; C Tancrede
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

2.  Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis.

Authors:  P I Fields; H J Schreier; A L Saha; R W Bernlohr
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

Review 3.  Classification of cephalosporins.

Authors:  J D Williams
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics.

Authors:  P J Wu; K Shannon; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 5.  The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years.

Authors:  R N Jones
Journal:  Infection       Date:  1994       Impact factor: 3.553

6.  The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.

Authors:  R M Ings; D S Reeves; L O White; R P Bax; M J Bywater; H A Holt
Journal:  J Pharmacokinet Biopharm       Date:  1985-04

7.  Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.

Authors:  M Limbert; D Isert; N Klesel; A Markus; K Seeger; G Seibert; E Schrinner
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

8.  Comparison of cefotaxime plus metronidazole versus cefoxitin for prevention of wound infection after abdominal surgery.

Authors:  L Kow; J Toouli; J Brookman; P J McDonald
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

9.  Cefotaxime lavage in children undergoing appendicectomy.

Authors:  T A McAllister; A H Fyfe; D G Young; P A Raine
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  Treatment of childhood bacterial meningitis.

Authors:  H Lecour; A Seara; J Cordeiro; M Miranda
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.